Antibiotic Use, Healthcare-Associated Infections, and Antimicrobial Resistance in Intensive Care Unit of a Serbian Tertiary University Hospital, 2018–2024: An Ecological Analysis

<b>Background</b>: Healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and antibiotic use (AU) remain critical challenges in intensive care units (ICUs). Reliable long-term surveillance is essential to inform stewardship programs and infection prevention. <b>Methods</b>: We conducted a seven-year ecological study (2018-2024) of adult patients admitted to the surgical ICU of a Serbian tertiary university hospital. Patients with ICU stays >48 h were included. Data on demographics, HAIs, AU expressed as 'days of therapy' (DOT) per 100 patient-days, and resistance profiles of key pathogens were collected. AU was classified by WHO Access, Watch and Reserve categories. Trends were analyzed, and correlations between AU and healthcare-associated <i>Clostridioides difficile</i> infection (HA-CDI) incidence density as well as changes in AMR rates were assessed. Direct expenditures for antibiotic therapy were also calculated. <b>Results:</b> Among 2055 patients, 511 (24.9%) developed at least one HAI. HA-CDI showed a marked upward trend. Overall, AU was stable, but Reserve antibiotics increased significantly (R<sup>2</sup> = 0.456), particularly linezolid, colistin, and ceftazidime-avibactam. Resistance to carbapenems and colistin in <i>Klebsiella pneumoniae</i> (<i>K. pneumonia</i>) demonstrated alarming trends. A strong correlation was observed between colistin use and colistin resistance in <i>K. pneumoniae</i>. Antibiotic expenditures peaked in 2023 at more than double pre-COVID levels, mainly driven by Reserve agents. <b>Conclusions:</b> This study reveals a concerning rise in multidrug-resistant pathogens, escalating Reserve antibiotic use, and substantial financial burden. Strengthened antimicrobial stewardship, optimization of Access, restriction of Reserve agents, and investment in infection prevention and surveillance are urgently needed.

Authors

Institutions

Publication Details

Journal
Antibiotics
Published
2025-11-04
DOI
https://doi.org/10.3390/antibiotics14111110
Citations
1
Primary Topic
Nosocomial Infections in ICU
Type
article
Field-Weighted Citation Impact
1.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antibiotic Use, Healthcare-Associated Infections, and Antimicrobial Resistance in Intensive Care Unit of a Serbian Tertiary University Hospital, 2018–2024: An Ecological Analysis

Danijela Đurić-Petković, Nemanja Rančić, Vojislava Nešković, Ivan Leković et al.
1 citations
Antibiotics
Nosocomial Infections in ICU
1.55
article

Antibiotic Use, Healthcare-Associated Infections, and Antimicrobial Resistance in Intensive Care Unit of a Serbian Tertiary University Hospital, 2018–2024: An Ecological Analysis

Danijela Đurić-Petković, Nemanja Rančić, Vojislava Nešković, Ivan Leković, Nenad Perišić, Đorđe Taušan, Katarina Radisavljevic Vasiljevic, Ivo Udovičić, Duško Maksimović, Bojan Rakonjac, Vesna Šuljagić
article en
1 citations

Abstract

<b>Background</b>: Healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and antibiotic use (AU) remain critical challenges in intensive care units (ICUs). Reliable long-term surveillance is essential to inform stewardship programs and infection prevention. <b>Methods</b>: We conducted a seven-year ecological study (2018-2024) of adult patients admitted to the surgical ICU of a Serbian tertiary university hospital. Patients with ICU stays >48 h were included. Data on demographics, HAIs, AU expressed as 'days of therapy' (DOT) per 100 patient-days, and resistance profiles of key pathogens were collected. AU was classified by WHO Access, Watch and Reserve categories. Trends were analyzed, and correlations between AU and healthcare-associated <i>Clostridioides difficile</i> infection (HA-CDI) incidence density as well as changes in AMR rates were assessed. Direct expenditures for antibiotic therapy were also calculated. <b>Results:</b> Among 2055 patients, 511 (24.9%) developed at least one HAI. HA-CDI showed a marked upward trend. Overall, AU was stable, but Reserve antibiotics increased significantly (R<sup>2</sup> = 0.456), particularly linezolid, colistin, and ceftazidime-avibactam. Resistance to carbapenems and colistin in <i>Klebsiella pneumoniae</i> (<i>K. pneumonia</i>) demonstrated alarming trends. A strong correlation was observed between colistin use and colistin resistance in <i>K. pneumoniae</i>. Antibiotic expenditures peaked in 2023 at more than double pre-COVID levels, mainly driven by Reserve agents. <b>Conclusions:</b> This study reveals a concerning rise in multidrug-resistant pathogens, escalating Reserve antibiotic use, and substantial financial burden. Strengthened antimicrobial stewardship, optimization of Access, restriction of Reserve agents, and investment in infection prevention and surveillance are urgently needed.

AntibioticsVol. 14(11)
Military Medical Academy (RS), University of Defence (RS)
Openalex Percentile: Top 14%
Nosocomial Infections in ICU
1.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.